A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 179 (1) , 62-70
- https://doi.org/10.1016/s0002-9378(98)70294-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal Of Cancer, 1996
- Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifenEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Tamoxifen and the uterus: an old drug tested by new modalitiesUltrasound in Obstetrics & Gynecology, 1996
- Breast Cancer: Long-Term Tamoxifen Trial HaltedScience, 1995
- Unusual ultrasonographic appearance of uterus in postmenopausal patients receiving tamoxifenAmerican Journal of Obstetrics and Gynecology, 1995
- Postmenopausal Tamoxifen Treatment and Endometrial PathologyObstetrical & Gynecological Survey, 1994
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen‐associated endometrial polypsUltrasound in Obstetrics & Gynecology, 1994
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Hysteroscopic follow-up during Tamoxifen treatmentEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990